NO and CO: overview of their diagnostic potential in the critically ill patient

N. Marczin (Harefield, United Kingdom)

Source: Annual Congress 2005 - PG6 - New and old methodologies to assess pathobiological markers in the lung and airways: from research into clinical practice
Disease area: Respiratory critical care

PDF journal article, handout or slidesSlide presentation

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
N. Marczin (Harefield, United Kingdom). NO and CO: overview of their diagnostic potential in the critically ill patient. Annual Congress 2005 - PG6 - New and old methodologies to assess pathobiological markers in the lung and airways: from research into clinical practice

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Exhaled breath condensate (EBC): what is sampled and how should it be collected? (recommendations and open issues)
Source: Annual Congress 2007 - ERS/ATS joint symposium: the report of the ERS/ATS Task Force on Exhaled Breath Condensate
Year: 2007


Exhaled breath condensate sample collection: standards and open issues
Source: Eur Respir Monogr 2010; 49: 152-161
Year: 2010


Assessing inflammation non invasively: induced sputum, fractional exhaled nitric oxide concentration (FeNO), exhaled breath condensate (EBC)
Source: Annual Congress 2006 - "Inflammometry": an alternative strategy in the management of airways disease
Year: 2006


Noninvasive assessment of airway inflammation in asthma
Source: ISSN=1025-448x, ISBN=1-904097-26-x, page=164
Year: 2003

Measuring exhaled NO and breath condensate: where do we stand?
Source: Annual Congress 2006 - PG14 - Noninvasive monitoring of asthma inflammation and treatment
Year: 2006



Determine the relationship between fraction exhaled nitric oxide (FeNO) and mannitol challenge test in the diagnosis of suspected asthma patients.
Source: Virtual Congress 2020 – Clinical and functional evaluation of asthmatics
Year: 2020


Longitudinal analysis between exhaled nitric oxide (FeNO), inflammatory markers (IM) in exhaled breath condensate (EBC), lung function, and control/severity of childhood asthma
Source: Annual Congress 2007 - Assessing asthma severity and control in children
Year: 2007


Exhaled aldehydes as markers of disease in critically ill patients
Source: Annual Congress 2007 - Acute lung injury and inflammation
Year: 2007


Noninvasive estimation of inflammation and remodelling
Source: Annual Congress 2006 - PG4 - Asthma: pathology and treatment
Year: 2006



Usefulness of fractional exhaled nitric oxide (FeNO) for early diagnosis of asthma in patients with nonspecific respiratory symptoms
Source: Annual Congress 2009 - From cough to sound analysis of breathing
Year: 2009


What is in the air of a child with lung disease?
Source: Annual Congress 2005 - Paediatric year in review
Year: 2005

Diagnosing asthma and prognostic significance of eNO
Source: Annual Congress 2005 - Are we ready for "inflammometry"? The role of eNO in asthma management
Year: 2005

Clinically relevant early functional and diagnostic markers of lung disease in children
Source: ISSN=ISSN 1025-448x, ISBN=ISBN 1-904097-50-2, page=120
Year: 2006

Exhaled air molecular profiling in relation to inflammatory subtype and activity in COPD
Source: Eur Respir J 2011; 38: 1301-1309
Year: 2011



Use of exhaled nitric oxide measurements to guide treatment in chronic asthma
Source: Annual Congress 2006 - Scientific year in review
Year: 2006


Low exhaled nitric oxide levels in infants with respiratory symptoms in the first 2 months of life
Source: Annual Congress 2006 - Markers of paediatric airway disease
Year: 2006


The possibility of using the level of concentration Fe2 + in the exhaled breath condensate as a diagnostic indicator in pulmonary pathology
Source: Annual Congress 2013 –Tobacco use in different countries: crisis to disease
Year: 2013

Exhaled breath condensate biomarkers in COPD
Source: Eur Respir J 2008; 32: 472-486
Year: 2008



Relationships between the concentrations of NO, IL1β, TNF-α, IL-6 in exhaled breath condensate (EBC) and lung function in patient with COPD
Source: Eur Respir J 2005; 26: Suppl. 49, 61s
Year: 2005